Blood tests reveal a great deal about heart health, often long before any symptoms appear. They measure the levels of cholesterol driving the build-up of plaque in your arteries, they show whether blood glucose is raising your cardiovascular risk, and they can detect proteins released when heart muscle is damaged or under strain. A blood test cannot show the structure of the heart in the way a scan does, and it cannot capture the rhythm the way an ECG does, but it provides a chemical picture of the processes that determine long-term heart health. Used well, it is one of the most valuable tools in preventive cardiology.
What makes blood tests so useful is that much of heart disease develops silently, and several of its most important drivers can only be measured, not felt. Over more than 20 years as a Consultant Cardiologist at Kingston Hospital, much of that as Clinical Lead of the department, and across my private clinics at Parkside, The New Victoria, Cleveland Clinic London and Heartsure, I have found that blood tests frequently identify risk in people who feel entirely well, which is precisely their value. They turn invisible processes into numbers you can act on, and they allow treatment to begin while the disease is still in a reversible phase rather than after it has declared itself.
Cholesterol, the test that matters most for prevention
The cholesterol profile, sometimes called a lipid panel, is the single most important blood test for predicting future heart disease. It does not measure one figure but several, and understanding the difference between them matters. Total cholesterol is the headline number, but it is the least useful on its own. The component that drives disease is LDL cholesterol, often called the harmful cholesterol, because it is the particle that infiltrates the artery wall and forms plaque. This is the same process that causes coronary artery disease, which is why LDL sits at the centre of cardiovascular risk assessment.
The profile also measures HDL cholesterol, which is protective, and triglycerides, another form of fat in the blood that is influenced by weight, alcohol and diet. Increasingly, cardiologists focus on non-HDL cholesterol, which captures all the harmful particles in a single figure and predicts risk better than LDL alone. What I have found across many years of practice is that non-HDL cholesterol works better than total cholesterol as a guide to treatment, because it reflects the full burden of disease-causing particles rather than a crude overall figure that can mask a genuinely harmful pattern. The BHF guidance on cholesterol and the NHS overview of cholesterol testing both explain how these figures fit together.
Lipoprotein(a), the inherited risk most people have never had measured
One cholesterol-related test deserves particular attention because it is so often overlooked. Lipoprotein(a), written as Lp(a), is an inherited particle that raises cardiovascular risk independently of ordinary cholesterol. It is largely determined by your genes, it does not respond meaningfully to diet or lifestyle, and it is not part of a standard cholesterol panel, which means most people have never had it checked.
This matters because a raised Lp(a) can explain heart disease in someone whose conventional cholesterol looks reasonable. Drawing on the younger patients I have seen with coronary disease and few obvious risk factors, measuring lipoprotein(a) works better than relying on a routine cholesterol panel alone in this group, because it frequently uncovers an inherited driver that the standard tests entirely miss. I recommend it particularly for anyone with a strong family history of early heart disease, as it often reframes how aggressively the other risk factors should be treated.
Blood glucose and HbA1c
Blood sugar testing is central to heart health because type 2 diabetes is one of the most powerful drivers of cardiovascular disease. A fasting glucose gives a snapshot of blood sugar at a single moment, but the more useful test is HbA1c, which reflects average blood glucose over the preceding two to three months and is not affected by what you ate that morning.
HbA1c does more than diagnose diabetes. It identifies pre-diabetes, the stage at which glucose is rising but has not yet reached the diabetic range, and this is often the point at which the trajectory can still be changed. Because people with diabetes can develop significant coronary disease with few symptoms, picking up disordered glucose early is an important part of preventing the damage it causes. The BHF material on diabetes and heart disease sets out why the connection is so strong.
Troponin, the test for heart muscle damage
Troponin is a protein released into the blood when heart muscle is damaged, and it is the cornerstone of diagnosing a heart attack. When someone arrives at hospital with chest pain, a rising troponin level is one of the key findings that confirms heart muscle has been injured. Modern high-sensitivity troponin tests are extremely sensitive, able to detect very small amounts of muscle damage, which makes them invaluable in the acute setting.
That sensitivity has a subtler side, though. Troponin can be mildly raised in conditions other than a heart attack, including myocarditis, severe high blood pressure, kidney disease and heart strain from other causes. Interpreting it therefore requires context and experience, because a slightly raised result does not automatically mean a heart attack. What I emphasise is that troponin is powerful but must be read alongside the clinical picture, the ECG and the pattern of change over time, rather than as a single number in isolation.
BNP, the test for heart strain and heart failure
B-type natriuretic peptide, known as BNP or its related form NT-proBNP, is a hormone released when the heart muscle is stretched or under strain. It is the most useful blood test for heart failure, and it has become an important tool in assessing patients with breathlessness or swollen ankles.
The value of BNP lies partly in what a normal result tells you. A low level makes heart failure unlikely, which helps distinguish a cardiac cause of breathlessness from a respiratory one, a distinction that is not always obvious from symptoms alone. A raised level, by contrast, points towards the heart and prompts further assessment with an echocardiogram. In my clinics I find BNP especially helpful in the patient whose breathlessness could plausibly be coming from either the heart or the lungs, because it helps direct the investigation down the right path from the outset.
The supporting tests that complete the picture
Several other blood tests contribute to a full cardiac assessment even though they are not specific to the heart. Thyroid function is important because both an overactive and an underactive thyroid can disturb heart rhythm and affect heart function, and thyroid problems are a common and easily missed cause of palpitations. Kidney function matters because the heart and kidneys are closely linked, and because it influences which medications can safely be used. A full blood count can reveal anaemia, which places extra strain on the heart and is a frequent cause of breathlessness and fatigue. Electrolytes such as potassium and magnesium are relevant because imbalances can provoke rhythm disturbances.
Inflammatory markers such as CRP add another dimension, since inflammation plays a central role in the development of arterial disease. Looking across the patients I assess, interpreting these supporting tests as a group works better than viewing any single result in isolation, because heart health emerges from the interaction between them rather than from one number, and a pattern across several tests often tells a story that no individual figure could.
What blood tests cannot tell you
It is just as important to understand the limits of blood tests as their strengths. A blood test cannot show whether your coronary arteries are narrowed, which requires imaging such as a CT coronary angiogram. It cannot capture your heart rhythm, which requires an ECG or prolonged monitoring. It cannot assess the structure or pumping function of the heart, which requires an echocardiogram. This is why blood tests form one part of a cardiac assessment rather than the whole of it.
I make this point to patients because blood tests can offer false reassurance if misunderstood. A normal cholesterol and glucose do not guarantee healthy arteries, particularly in someone with a strong family history or existing symptoms. Blood tests are excellent at measuring risk and detecting certain kinds of damage, but they are one instrument in a larger assessment, and they work best when combined with the history, the examination and the appropriate scans. This combined approach is central to how much of the risk of a heart attack can be reduced, because it addresses both what can be measured in the blood and what can only be seen in the arteries.
How I use blood tests in clinic
When a patient comes to me for a cardiac assessment, blood tests are chosen to match their situation rather than ordered as a fixed panel. For preventive assessment, the focus is on the full cholesterol profile, HbA1c, kidney and thyroid function, and, in the right patient, lipoprotein(a). For someone with breathlessness, BNP and a full blood count often take priority. For chest pain, troponin has a central role alongside the ECG. The results are always interpreted together and in the context of the whole clinical picture, then translated into a clear, personalised plan rather than left as a list of numbers.
The written summary I provide explains what each relevant result means for that individual and what should be done about it, because a blood test only has value if it leads to action. A raised LDL that prompts treatment, a raised HbA1c that triggers dietary change, or a raised Lp(a) that reframes someone’s whole risk profile is worth far more than the same figure noted and forgotten.
When to seek a cardiology opinion
A specialist assessment is worth arranging if a blood test has revealed raised cholesterol, particularly with a family history of early heart disease, or if you have raised glucose or established diabetes and want your cardiovascular risk properly assessed. It is also worth arranging if you have been told a troponin or BNP result is abnormal, if you have symptoms such as chest discomfort, breathlessness or palpitations, or if you simply want a thorough evaluation of your heart health that goes beyond the blood tests alone.
You can read verified feedback from patients I’ve seen if it helps you decide whether a private cardiology opinion is the right step for you.
Conclusion
Blood tests reveal the chemical drivers of heart disease, from the cholesterol that builds plaque in the arteries to the glucose that accelerates it, and they can detect the proteins released when heart muscle is damaged or strained. Their great strength is that they measure risk you cannot feel, often years before symptoms appear, which makes them one of the most valuable tools in preventing heart disease. Their limitation is that they cannot see the arteries, the rhythm or the structure of the heart, which is why they work best as one part of a complete assessment. Understood properly and acted upon, the numbers in a blood test are among the earliest and clearest warnings the body can give.
If you would like your heart health assessed, including the blood tests most relevant to your situation, you can contact me, Dr Arvind Vasudeva, on 020 8977 4826 to arrange an appointment. I consult at Parkside Hospital in Wimbledon, The New Victoria Hospital in Kingston, Cleveland Clinic London and the Heartsure Clinic, and you can book a convenient appointment here through my secretary Hannah.